Correction to: Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.

MLA

Trigo, José, et al. “Correction to: Recommendations for the Use of Biomarkers for Head and Neck Cancer, Including Salivary Gland Tumours: A Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.” Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 25, no. 1, Jan. 2023, p. 292. EBSCOhost, https://doi.org/10.1007/s12094-022-02954-0.

APA

Trigo, J., García-Cosío, M., García-Castaño, A., Gomà, M., Mesia-Nin, R., Ruiz-Bravo, E., Soria-Rivas, A., Castillo, P., Braña-García, I., & Alberola-Ferranti, M. (2023). Correction to: Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology. Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 25(1), 292. https://doi.org/10.1007/s12094-022-02954-0

Chicago

Trigo, José, Mónica García-Cosío, Almudena García-Castaño, Montserrat Gomà, Ricard Mesia-Nin, Elena Ruiz-Bravo, Ainara Soria-Rivas, Paola Castillo, Irene Braña-García, and Margarita Alberola-Ferranti. 2023. “Correction to: Recommendations for the Use of Biomarkers for Head and Neck Cancer, Including Salivary Gland Tumours: A Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.” Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 25 (1): 292. doi:10.1007/s12094-022-02954-0.